PHARMA
Lilly Expands Partnership With China’s Novast
Building on an earlier 2012 agreement, Lilly intends to invest US$60-70 million in Chinese generics manufacturer Novast.
BioLight Eyes Chinese Glaucoma Market, Raises US$5.5 Million
Israeli investment group BioLight has raised US$5.5 million and plans to move into the world's largest glaucoma market, China.
Cipla Gets FDA Approval For Generic HIV Drug
Tentative approval for a generic HIV drug for use outside of the United States has been granted to Indian manufacturer Cipla.
Bayer Enters China’s TCM Market With Dihon Acquisition
Bayer's acquisition of Dihon is a part of a strategic move into the sizable TCM market in China.
Fosun Pharma And TPG To Acquire Chindex
Shanghai Fosun Pharmaceutical and TPG will acquire Chindex International for approximately $394 million.
Jubilant-Janssen Drug Discovery Alliance Expanded
India's Jubilant Biosys has expanded its drug discovery alliance with Belgium's Janssen Pharmaceutica to cover multiple therapeutic areas.
Sagent Launches Research Center In China
Sagent Pharmaceuticals has launched a National Research Center in Chengdu focusing on processes and methods for specialty injectables.
ASLAN Pharmaceuticals Opens Taiwan Office
Biotech company ASLAN Pharmaceuticals Pte Ltd, which is headquartered in Singapore, has opened a new office in Taipei, Taiwan.
Sinovac Seeks Approval For H7N9 Vaccine Clinical Trials
Sinovac Biotech has submitted a clinical trial application to commence clinical trials for its vaccine Avian influenza A (H7N9) vaccine.
